Lv7
4988 积分 2022-08-08 加入
In vitroandin vivopharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin
11小时前
已完结
Regulatory Forum Commentary* Counterpoint
21天前
已完结
Regulatory Forum Commentary* Counterpoint
21天前
已完结
Functional importance of GLP-1 receptor species and expression levels in cell lines
23天前
已完结
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
1个月前
已完结
Phase 2a Study of Baxdrostat in Primary Aldosteronism
1个月前
已完结
Aldosterone synthase inhibition: a novel bullet to fight cardiovascular–kidney–metabolic syndrome
1个月前
已关闭
Aldosterone Synthase Inhibition in Hypertension
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
1个月前
已完结
Optimal Use of Once-Weekly Basal Insulin Efsitora Alfa in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis
2个月前
已关闭
皖公网安备34019202002308
